{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T19:01:36Z","timestamp":1774983696053,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"vor","delay-in-days":1461,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1038\/ki.2011.416","type":"journal-article","created":{"date-parts":[[2011,12,21]],"date-time":"2011-12-21T19:26:29Z","timestamp":1324495589000},"page":"469-476","source":"Crossref","is-referenced-by-count":90,"title":["The prevalence of and factors associated with chronic atrial fibrillation in Medicare\/Medicaid-eligible dialysis patients"],"prefix":"10.1016","volume":"81","author":[{"given":"James B.","family":"Wetmore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan D.","family":"Mahnken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally K.","family":"Rigler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward F.","family":"Ellerbeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Purna","family":"Mukhopadhyay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Spertus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingjiang","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa I.","family":"Shireman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2011.416_bb0010","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/ki.1995.22","article-title":"Clinical and echocardiographic disease in patients starting end-stage renal disease therapy","volume":"47","author":"Foley","year":"1995","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.416_bb0015","series-title":"USRDS 2005 Annual Data Report: Atlas of End-Stage Renal Disease in the United States","author":"United States Renal Data System","year":"2005"},{"key":"10.1038\/ki.2011.416_bb0020","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0002-8703(96)90088-5","article-title":"Electrocardiographic abnormalities in patients receiving hemodialysis","volume":"131","author":"Abe","year":"1996","journal-title":"Am Heart J"},{"key":"10.1038\/ki.2011.416_bb0025","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1067\/mhj.2000.111111","article-title":"Influence of atrial fibrillation on the morbido-mortality of patients on hemodialysis","volume":"140","author":"Vazquez","year":"2000","journal-title":"Am Heart J"},{"key":"10.1038\/ki.2011.416_bb0030","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijcard.2004.12.048","article-title":"Frequency of atrial fibrillation and factors related to its development in dialysis patients","volume":"106","author":"Atar","year":"2006","journal-title":"Int J Cardiol"},{"key":"10.1038\/ki.2011.416_bb0035","first-page":"234","article-title":"Clinical characteristics associated to atrial fibrillation in chronic hemodialysis patients","volume":"54","author":"Fabbian","year":"2000","journal-title":"Clin Nephrol"},{"key":"10.1038\/ki.2011.416_bb0040","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1053\/j.ajkd.2005.07.044","article-title":"Prevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patients","volume":"46","author":"Genovesi","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2011.416_bb0045","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1038\/ki.2009.477","article-title":"Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy","volume":"77","author":"Wizemann","year":"2010","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.416_bb0050","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1111\/j.1540-8159.2007.00877.x","article-title":"Atrial fibrillation in end-stage renal disease","volume":"30","author":"Korantzopoulos","year":"2007","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1038\/ki.2011.416_bb0055","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","article-title":"Impact of atrial fibrillation on the risk of death: the Framingham Heart Study","volume":"98","author":"Benjamin","year":"1998","journal-title":"Circulation"},{"key":"10.1038\/ki.2011.416_bb0060","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/ki.2009.185","article-title":"Atrial fibrillation in incident dialysis patients","volume":"76","author":"Vazquez","year":"2009","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.416_bb0065","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1681\/ASN.2009030319","article-title":"Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation","volume":"20","author":"Chan","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.416_bb0070","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1681\/ASN.2010050459","article-title":"The increasing prevalence of atrial fibrillation among hemodialysis patients","volume":"22","author":"Winkelmayer","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.416_bb0075","doi-asserted-by":"crossref","first-page":"927","DOI":"10.7326\/0003-4819-131-12-199912210-00004","article-title":"Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study","volume":"131","author":"Go","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1038\/ki.2011.416_bb0080","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"key":"10.1038\/ki.2011.416_bb0085","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/ndt\/gfp396","article-title":"Considering health insurance: how do dialysis initiates with Medicaid coverage differ from persons without Medicaid coverage?","volume":"25","author":"Wetmore","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2011.416_bb0090","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1001\/jama.290.20.2685","article-title":"Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?","volume":"290","author":"Go","year":"2003","journal-title":"JAMA"},{"key":"10.1038\/ki.2011.416_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2369-4-1","article-title":"Atrial fibrillation in chronic dialysis patients in the United States: risk factors for hospitalization and mortality","volume":"4","author":"Abbott","year":"2003","journal-title":"BMC Nephrol"},{"key":"10.1038\/ki.2011.416_bb0100","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"},{"key":"10.1038\/ki.2011.416_bb0105","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","author":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults","year":"2001","journal-title":"JAMA"},{"key":"10.1038\/ki.2011.416_bb0110","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0895-4356(03)00055-6","article-title":"Coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC) study","volume":"56","author":"Chambless","year":"2003","journal-title":"J Clin Epidemiol"},{"key":"10.1038\/ki.2011.416_bb0115","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.2337\/diacare.26.10.2777","article-title":"Prediction of coronary heart disease in middle-aged adults with diabetes","volume":"26","author":"Folsom","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1038\/ki.2011.416_bb0120","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0140-6736(09)60443-8","article-title":"Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study","volume":"373","author":"Schnabel","year":"2009","journal-title":"Lancet"},{"key":"10.1038\/ki.2011.416_bb0125","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.amjcard.2010.08.049","article-title":"A clinical risk score for atrial fibrillation in a biracial prospective cohort (from the Atherosclerosis Risk in Communities [ARIC] study)","volume":"107","author":"Chamberlain","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1038\/ki.2011.416_bb0130","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1525-139X.2007.00363.x","article-title":"Introduction: the reverse epidemiology controversy","volume":"20","author":"Kovesdy","year":"2007","journal-title":"Semin Dial"},{"key":"10.1038\/ki.2011.416_bb0135","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1525-139X.2007.00360.x","article-title":"What is so bad about reverse epidemiology anyway?","volume":"20","author":"Kalantar-Zadeh","year":"2007","journal-title":"Semin Dial"},{"key":"10.1038\/ki.2011.416_bb0140","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1093\/ndt\/gfl078","article-title":"Racial disparities in the prevalence of cardiovascular disease among incident end-stage renal disease patients","volume":"21","author":"Volkova","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2011.416_bb0145","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1681\/ASN.2005111241","article-title":"Increasing body mass index and obesity in the incident ESRD population","volume":"17","author":"Kramer","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.416_bb0150","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/ndt\/gfn426","article-title":"Risk factors for non-fatal myocardial infarction cardiac death in incident dialysis patients","volume":"24","author":"Trivedi","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2011.416_bb0155","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1111\/j.1475-6773.2009.00990.x","article-title":"Provider monitoring and pay-for-performance when multiple providers affect outcomes: an application to renal dialysis","volume":"44","author":"Hirth","year":"2009","journal-title":"Health Serv Res"},{"key":"10.1038\/ki.2011.416_bb0160","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1542-4758.2009.00396.x","article-title":"Hemodialysis access at initiation in the United States, 2005 to 2007: still \u201ccatheter first\u201d","volume":"13","author":"Foley","year":"2009","journal-title":"Hemodial Int"},{"key":"10.1038\/ki.2011.416_bb0165","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1159\/000303754","article-title":"Mortality from cancer among US hemodialysis patients, 1995\u20132005","volume":"31","author":"Foley","year":"2010","journal-title":"Am J Nephrol"},{"key":"10.1038\/ki.2011.416_bb0170","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1053\/j.ajkd.2010.04.016","article-title":"Infection-related hospitalizations in older patients with ESRD","volume":"56","author":"Dalrymple","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2011.416_bb0175","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/ki.2009.413","article-title":"An improved comorbidity index for outcome analyses among dialysis patients","volume":"77","author":"Liu","year":"2010","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.416_bb0180","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/ki.2009.431","article-title":"Comorbidity and confounding in end-stage renal disease","volume":"77","author":"Seliger","year":"2010","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.416_bb0185","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1164\/rccm.200210-1231OC","article-title":"Effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease: immortal time bias in observational studies","volume":"168","author":"Suissa","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1038\/ki.2011.416_bb0190","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"10.1038\/ki.2011.416_bb0195","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1046\/j.1523-1755.2003.00101.x","article-title":"Elevated risk of stroke among patients with end-stage renal disease","volume":"64","author":"Seliger","year":"2003","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.416_bb0200","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa022913","article-title":"Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation","volume":"349","author":"Hylek","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2011.416_bb0205","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1345\/aph.1G408","article-title":"Warfarin exposure and the risk of thromboembolic and major bleeding events among medicaid patients with atrial fibrillation","volume":"40","author":"Boulanger","year":"2006","journal-title":"Ann Pharmacother"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815553325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815553325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T05:33:02Z","timestamp":1561095182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815553325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0085253815553325"],"URL":"https:\/\/doi.org\/10.1038\/ki.2011.416","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}